Therapeutic potential of cationic steroid antibacterials

Expert Opinion on Investigational Drugs

Volumn 16, Issue 8, 2007, Pages 1143-1157

  Salmi, Chanaz ^a   Brunel, Jean M ^a  

^a Aix Marseille University   (France)

Author keywords

Antibacterial activities; Cationic steroid derivatives; Gram negative bacteria; Permeabilization; Polymyxin B mimics

Indexed keywords

20 (N,N DIMETHYLAMINO) 3' (3' PHENYL 2' PROPENYL N METHYLAMIDO)PREGNANE; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CHOLIC ACID DERIVATIVE; EPIPACHYSAMINE DEXTRO[20 (N,N DIMETHYLAMINO) 3' BENZAMIDO]PREGNANE; ERYTHROMYCIN; N METHYL EPIPACHYSAMINE DEXTRO[20 (N,N DIMETHYLAMINO) 3A N METHYLBENZAMIDO]PREGNANE; NOVOBIOCIN; POLYMYXIN B; POLYMYXIN DERIVATIVE; SQUALAMINE; STEROID; TRODUSQUEMINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; DRUG ISOLATION; DRUG PENETRATION; DRUG POTENTIATION; DRUG STRUCTURE; ENTEROCOCCAL INFECTION; GRAM NEGATIVE INFECTION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; POLYMERIZATION; REVIEW; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CATIONS; CELL MEMBRANE PERMEABILITY; HUMANS; POLYMYXINS; STEROIDS;

EID: 34548291486     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.16.8.1143     Document Type: Review

References (42)

1. ARMSTRONG D, NEU H, PETERSON LR, TOMASZ A: The prospects of treatment failure in the chemotherapy of infectious diseases in the 1990s. Microb. Drug Resist. (1995) 1:1-4.
2. TOMASZ A: Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University workshop. N. Engl. J. Med. (1994) 330:1247-1251.
3. BAX R, BYWATER R, CORNAGLIA G et al.: Surveillance of antimicrobial resistance - what, how and whither? Clin. Microbiol. Infect. (2001) 7:316-325.
4. LABISCHINSKI H, BARNICKEL G, BRADACZEK H, NAUMANN DT, GIESBRECHT P: High state of order of isolated bacterial lipopolysaccharide and its possible contribution to the permeation barrier property of the outer membrane. J. Bacteriol. (1985) 162:9-20.
5. RIETSCHEL ET, BRADE H, HOLST O et al.: Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr. Top. Microbiol. Immunol. (1996) 216:39-81.
6. SAVAGE PB, LI C, TAOTAFA U, DING B, GUAN Q: Antibacterial properties of cationic steroid antibiotics. FEMS Microbiol. Lett. (2002) 217:1-7.
7. VAARA M: Agents that increase the permeability of the outer membrane. Microbiol. Rev. (1992) 56:395-411.
8. SEYDEL U, OIKAWA M, FUKASE K, KUSIMOTO S, BRANDENBURG K: Intrinsic conformation of lipid A is responsible for agonistic and antagonistic activity. Eur J. Biochem. (2000) 267:3032-3039.
9. HANCOCK R: The bacterial outer membrane as a drug barrier. Trends Microbiol. (1997) 5:37-42.
10. NIKAIDO H: Outer membrane. In: Escherichia coli and Salmonella: Cellular and Molecular Biolvgy. Neidhardt FC, Curtis R III, Ingraham JL (Eds), ASM Press, Washington, USA (1996):29-47.
11. FISHER W: Lipoteichoic acid and lipids in the membrane of Stapbylococcus aureus. Med. Microbiol. Immunol. (1994) 183:61-76.
12. VAARA M: Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in Gram-negative enteric bacteria. Antimicrob. Agents Chemother. (1993) 37:354-356.
13. ZASLOFF M: Antibacterial molecules from frogs, sharks and man. Phylogenet. Perspect. Immun. Insect Host Def. (1994):31-41.
14. JAYASINGHE ULB, NADEEM M, ATTA R UR, CHOUDHARY MI, RATNAYAKE HD, AMTUL Z: New antibacterial steroidal alkaloids from Sarrococca brevifolia. Nat. Prod. Lett. (1998) 12:103-109.
15. ATTA R UR, ANJUM S, FAROOQ A, KHAN MR, PARVEEN Z, CHOUDHARY MI: Antibacterial steroidal alkaloids from Sarrococca saligna. J. Nat. Prod. (1998) 61:202-206.
16. BOMAN HG: Antibacterial peptides: key components needed in immunity. Cell (1991) 65:205-207.
17. ZASLOFF M: Antibiotic peptides as mediators of innate immunity. Curr. Opin. Immunol. (1992) 4:3-7.
18. STONE R: Deja vu guides the way to new antimicrobial steroid. Science 259:1125.
19. CHO J, KIM Y: Sharks: a potential source of antiangiogenic factors and tumor treatments. Marine Biotechnol. (2002) 4:521-525.
20. BRUNEL JM, SALMI C, LONCLE C, VIDAL N, LETOURNEUX Y: Squalamine: a polyvalent drug of the future? Curr. Cancer Drug Targets (2005) 5:267-272.
21. BRUNEL JM, LETOURNEUX Y: Recent advances in the synthesis of spermine and spermidine analogs of the shark aminosterol squalamine. Eur. J. Org. Chem. (2003):3897-3907.
22. MOORE KS, WEHRLI S, RODER H et al.: Squalamine: an aminosterol antibiotic from the shark. Proc. Natl. Acad. Sci. USA (1993) 90:1354-1358.
23. RAO MN, SHINNAR AE, NOECKER LA et al.: Aminosterols from the dogfish shark Squalus acanthias. J. Nat. Prod. (2000) 63:631-635.
24. DING B, GUAN Q, WALSH JP et al.: Correlation of the antibacterial activities of cationic peptide antibiotics and cationic steroid antibiotics. J. Med. Chem. (2002) 45:663-669.
25. SAVAGE PB: Cationic steroid antibiotics. Curr. Med. Chem. Anti-Infective Agents (2002) 1:293-304.
26. SAVAGE PB: Design, synthesis and characterization of cationic peptide and steroid antibiotics. Eur. J. Org Chem. (2002):759-768.
27. YASUDAK, OHMIZO C, KATSU T: Mode of action of novel polyamines increasing the permeability of bacterial outer membrane. Int. J. Antimicrob. Agents (2004) 24:67-71.
28. SAVAGE PB, LI C: Cholic acid derivatives: novel antimicrobials. Expert Opin. Investig. Drugs (2000) 9(2):263-272.
29. SELINSKY BS, ZHOU Z, FOJTIK KG, JONES SR, DOLLAHON NR, SHINNAR AE: The aminosterol antibiotic squalamine permeabilizes large unilamellar phospholipid vesicles. Biochimica et Biophysica Acta (1998) 1370:218-234.
30. SHU Y, JONES SR, KINNEY WA, SELINSKY BS: The synthesis of spermine analogs of the shark aminosterol squalamine. Steroids (2002) 67:291-304.
31. VAARA M: The outer membrane permeability-increasing action of linear analogs of polymyxin B nonapeptide. Drugs Exp. Clin. Res. (1991) 17:437-444.
32. MORRIS CM, GEORGE A, WILSON WW, CHAMPLIN FR: Effect of polymyxin B nonapeptide on daptomycin permeability and cell surface properties in Pseudomonas aeruginosa, Escherichia coli, and Pasteurella multocida. J. Antibiot. (1995) 48(1):67-72.
33. LI C, PETERS AS, MEREDITH EL, ALLMAN GW, SAVAGE PB: Design and synthesis of potent sensitizers of gram-negative bacteria based on a cholic acid scaffolding. J. Am. Chem. Soc. (1998) 120:2961-2962.
34. HSIEH HP, MULLER JG, BURROWS Cj: Synthesis and DNA binding properties of C3-, C12-, and C24-substituted amino-steroids derived from bile acids. Bioorg. Med. Chem. (1995) 3:823-838.
35. LI C, BUDGE LP, DRISCOLL CD, WILLARDSON BM, ALLMAN GW SAVAGE PB: Incremental conversion of outer-membrane permeabilizers into potent antibiotics for gram-negative bacteria. J. Am. Cbem. Soc. (1999) 121:931-940.
36. ELION GB, SINGERS, HITCHINS GH: Antagonists of nucleic acid derivatives. VIII. Synergism in combinations of biochemically related antimetabolites. J. Biol. Chem. (1954) 208:477-488.
37. WIESE A, MUNSTERMANN M, GUTSMANN T et al.: Molecular mechanisms of polymyxin B-membrane interactions: direct correlation between surface charge density and self-promoted transport. J. Membrane Biol. (1998) 162:127-138.
38. KIKUCHI K, BERNARD EM, SADOWNIK A, REGEN SL, ARMSTRONG D: Antimicrobial activities of squalamine mimics. Antimicrob. Agents Chemother. (1997) 41:1433-1438.
39. HANCOCK RFW: Alterations in outer membrane permeability. Ann. Rev. Microbiol. (1984) 38:237-264.
40. LI C, LEWIS MR, GILBERT AB et al.: Antimicrobial activities of amine- and guanidine-functionalized cholic acid derivatives. Antimicrob. Agents Chemother. (1999) 43:1347-1349.
41. ATIQ R UR, LI C, BUDGE LP, STREET SE, SAVAGE PB: Preparation of amino acid-appended cholic acid derivatives as sensitizers of Gram-negative bacteria. Tetrahedron Lett. (1999) 40:1865-1868.
42. SCHMIDT EJ, BOSWELL JS, WALSH JP et al.: Activities of cholic acid-derived antimicrobial agents against multidrug-resistant bacteria. J. Antimicrob. Chemother. (2001) 47:671-674.